Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)

The rate of inherent resistance to single-agent trastuzumab in HER2-overexpressing metastatic breast carcinomas is impressive at above 70%. Unfortunately, little is known regarding the distinctive genetic signatures that could predict trastuzumab refractoriness ab initio. The epithelial-to-mesenchym...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Oliveras-Ferraros, Cristina, Corominas-Faja, Bruna, Cufí, Sílvia, Vazquez-Martin, Alejandro, Martin-Castillo, Begoña, Iglesias, Juan Manuel, López-Bonet, Eugeni, Martin, Ángel G., Menendez, Javier A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2012
Témata:
Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507497/
https://ncbi.nlm.nih.gov/pubmed/22992620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.22225
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky